8-K
filed May 21, 2026, 5:28 PM ET
ticker IMMX
CIK 0001873835
other material
confidence high
sentiment positive
materiality 0.70
Immix Biopharma prices $150M public offering of 16.8M shares at $8.94
Immix Biopharma, Inc.
- Gross proceeds $150M; net proceeds ~$140.65M after discounts and expenses.
- Offering of 16,778,524 shares priced at $8.94 per share; closes May 22, 2026.
- Net proceeds to fund NXC-201 development, working capital, and general corporate purposes.
- Cash runway extended to mid-2028 with existing cash plus offering net proceeds.
- Morgan Stanley leads underwriters; BofA Securities, LifeSci Capital, Mizuho, Needham co-manage.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-024872
- form_type
- 8-K
- ticker
- IMMX
- cik
- 0001873835
- company_name
- Immix Biopharma, Inc.
- filed_at
- 2026-05-21T21:28:23+00:00
- discovered_at
- 2026-05-21T21:30:00.387059+00:00
- generated_at
- 2026-05-21T21:33:41.397973+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-024872
- json_url
- https://secwatch.observer/filing/0001493152-26-024872.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-024872.md
- text_url
- https://secwatch.observer/filing/0001493152-26-024872.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1873835/000149315226024872/0001493152-26-024872-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1873835/000149315226024872/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
PECE
Peace Acquisition Corp closes IPO of 6M units at $10.00/unit, raising $60M
Peace Acquisition Corp.
June 1, 2026, 5:16 PM ET
other_material
Items 3.02, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MUX
McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M
McEwen Inc.
June 1, 2026, 5:14 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MVIS
MicroVision seeks reverse stock split approval; ratio 1:5 to 1:15; annual meeting July 10, 2026
MICROVISION, INC.
June 1, 2026, 5:02 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
VDTA
Vertical Data launches Vertical Edge, a direct-ownership edge data center platform
Vertical Data Inc.
June 1, 2026, 4:47 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
XAIR
Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026
Beyond Air, Inc.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTOR
Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer
CITIUS ONCOLOGY, INC.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CSR
Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City
CENTERSPACE
June 1, 2026, 4:30 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.